Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2° Year activated in the A.Y. 2020/2021
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Quality assessment of clinical practice - FARMACOLOGIA: SISTEMI DI SICUREZZA NELLA GESTIONE DELLA TERAPIA (2020/2021)
Teaching code
4S000437
Teacher
Credits
2
Language
Italian
Scientific Disciplinary Sector (SSD)
BIO/14 - PHARMACOLOGY
Period
LMSIO BZ - 2° ANNO 1° SEM. dal Oct 8, 2020 al Feb 13, 2021.
To show the organization of the course that includes this module, follow this link: Course organization
Learning outcomes
Precision medicine: develop skills for projecting and applying pharmacological therapy/ies according to concepts of appropriateness and efficacy by combining the relevant information about the drug/s with the characteristics of the individual patients, the context where the disease develops and is treated. The student will be exposed to the principles governing drug validation: EBM, the principles of information and relevance of scientific data and their validity, clinical studies, ethic commeettees, consulting data banks for clinical studies.
Analysis of vaccine and drug development for treatment of COVID-19 nfection
EMB in practice: the real-world medicine
Learn to use models of PK and pharmacogenetics to maximize benefits and reduce ADRs in individual patients
Understand significance, limits and advantages produced by post-marketing followup of drugs (i.e. pharmacosurveillance) also by knowing the methodologies and the practical aspects of these processes.
Become aware of application of new biotechnologies for treatments of diseases, including cell therapies.
Program
1- Precision medicine: definition
Evidence-based medicine: significance and evolution to Real World Evidence
Practical significance of Evidence-based medicine: classification of evidences, how are they generated and organization of a clinical trial: from case report to randomized trials. The authorities monitoring and governing drug use in therapies.
Principles of experimental drug research
New aspects of drug development: ethics and patient involvement, significance of PK and pharmacogenomics for individualization and appropriateness of therapy .
2- Postmarketing followup of drugs: the “how”, the sources and the methodologies of informations, the data bases of drug surveillance
3- PK: advanced use of PK principles for therapy adaptation to patient and disease
4- Biotechnology: generation, use and administrative aspects of biotechnology drugs, including cells.
| Author | Title | Publishing house | Year | ISBN | Notes |
|---|---|---|---|---|---|
| F. Rossi, V. Cuomo, C. Riccardi | Farmacologia (Edizione 3) | Minerva Medica | 2017 | 978-88-7711-881-3 | |
| B. G. Katzung & A. J. Trevor | Farmacologia Generale e Clinica (Edizione 10) | Piccin-Nuova Libraria | 2017 | 978-88-299-2847-7 | |
| A. Conforti, L. Cuzzolin, R. Leone, U. Moretti, G. Pignataro, M. Taglialatela, M. Vanzetta | Farmacologia per le professioni sanitarie (Edizione 1) | Idelson-Gnocchi | 2015 | 978-88-7947-592-1 |
Examination Methods
Written, questions with multiple choice answers
